Infection of "nonprofessional phagocytes" with Mycobacterium avium complex (Q41657770)

6 October 2017

title

Infection of "nonprofessional phagocytes" with Mycobacterium avium complex (English)

1 reference

Mycobacterium avium avium

6 October 2017

main subject

1 reference

Bermudez LE

1

1 reference

6 October 2017

publication date

1 November 1991

1 reference

Clinical Immunology and Immunopathology

6 October 2017

published in

1 reference

6 October 2017

volume

61

1 reference

6 October 2017

issue

2 Pt 1

1 reference

6 October 2017

page(s)

225-235

1 reference

Mode of entry and release of chlamydiae in infections of intestinal epithelial cells

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980026-1

7 January 2021

Mycobacterium avium complex infection

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980026-1

7 January 2021

Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980026-1

7 January 2021

Recombinant granulocyte-macrophage colony-stimulating factor activates human macrophages to inhibit growth or kill Mycobacterium avium complex

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980026-1

7 January 2021

In vitro and in vivo activity of azithromycin (CP 62,993) against the Mycobacterium avium complex

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980026-1

7 January 2021

Treatment of disseminated Mycobacterium avium complex infection in AIDS with amikacin, ethambutol, rifampin, and ciprofloxacin. California Collaborative Treatment Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980026-1

7 January 2021

A rapid method for the isolation of functional thymus-derived murine lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980026-1

7 January 2021

Confirmation of the beige mouse model for study of disseminated infection with Mycobacterium avium complex

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980026-1

7 January 2021

1,25 Dihydroxyvitamin D3-dependent inhibition of growth or killing of Mycobacterium avium complex in human macrophages is mediated by TNF and GM-CSF

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980026-1

7 January 2021

Determination of in vitro susceptibility of Mycobacterium avium complex isolates to antimycobacterial agents by various methods

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980026-1

7 January 2021

Natural killer cell activity and macrophage-dependent inhibition of growth or killing of Mycobacterium avium complex in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980026-1

7 January 2021

Natural killer cells induced by acute and chronic toxoplasma infection

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980026-1

7 January 2021

Inhibition of the growth of Rickettsia prowazekii in cultured fibroblasts by lymphokines

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980026-1

7 January 2021

Comparison of the properties of antirickettsial activity and interferon in mouse lymphokines

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980026-1

7 January 2021

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980026-1

7 January 2021

Plasmid profiles of mycobacterium avium/intracellulare isolated from patients with AIDS or cervical lymphadenitis and from environmental samples

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980026-1

7 January 2021

Disseminated Mycobacterium avium-intracellulare infection in homosexual men dying of acquired immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980026-1

7 January 2021

Mycobacterial infections in AIDS patients, with an emphasis on the Mycobacterium avium complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980026-1

7 January 2021

Activities of amikacin, roxithromycin, and azithromycin alone or in combination with tumor necrosis factor against Mycobacterium avium complex

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980026-1

7 January 2021

Phagocytosis of leprosy bacilli is mediated by complement receptors CR1 and CR3 on human monocytes and complement component C3 in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980026-1

7 January 2021

Mechanism of cytotoxicity by natural killer (NK) cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980026-1

7 January 2021

Immune responses to atypical mycobacterial lung infections

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980026-1

7 January 2021

Acidic fibroblast growth factor modulates Staphylococcus aureus adherence to human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980026-1

7 January 2021

Interferons with Special Emphasis on the Immune System

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980026-1

7 January 2021

Inhibition by 1,25(OH)2-vitamin D3 of the multiplication of virulent tubercle bacilli in cultured human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2805%2980026-1

7 January 2021

10.1016/S0090-1229(05)80026-1

Identifiers

DOI

1 reference

6 October 2017

1 reference